Member Info for baf3

MicroSalt plc

("MicroSalt" or the "Company")

Loblaws Supermarkets onboards MicroSalt® shakers

& LeBeau Excel Appointed as Canadian Food Broker

MicroSalt plc (AIM: SALT), a leading provider of full-flavour, natural salt with approximately 50% less sodium is excited to announce the expansion of its retail distribution of its domestic-use saltshakers with a new placement in Loblaws, one of Canada's largest supermarket retailers.

The new distribution is for both the 2oz and 6oz saltshakers which are expected to be available in stores by October 2024. United Natural Foods will be the distribution partner to support the Loblaws placement.

MicroSalt is also pleased to announce it has retained LeBeau Excel sales and marketing brokerage, a leading food broker in the Canadian natural and organic industry, to support and expand sales within the Canadian market.

Rick Guiney, CEO of MicroSalt, said:

"We are extremely excited about the placement of MicroSalt® shakers in Loblaws. Loblaws is one of the largest supermarket chains in Canada and a prominent fixture in the Canadian food landscape. Additionally, we are enthusiastic to partner with LeBeau Excel to expand our business, across all customer channels in Canada."

About Loblaws

Loblaws is well known for its innovative private label products such as No Name® and President's Choice®, which offer high-quality goods at competitive prices. Loblaws operates over 2,400 stores across Canada, many of which are run by independent owners, providing a full range of shopping experiences, from discount outlets like No Frills® to more upscale options like Loblaws CityMarket. In addition to groceries, Loblaw also owns Shoppers Drug Mart, offering pharmaceuticals and health services, further cementing its position as a significant retailer in Canada. For further information about Loblaws, see https://www.loblaws.ca/.

About MicroSalt®

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers and is a potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium.

Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK.

Microsalt's all natural, low-sodium solution is well positioned to take advantage of the fast-growing market for

MicroSalt plc

("MicroSalt" or the "Company")

Loblaws Supermarkets onboards MicroSalt® shakers

& LeBeau Excel Appointed as Canadian Food Broker

MicroSalt plc (AIM: SALT), a leading provider of full-flavour, natural salt with approximately 50% less sodium is excited to announce the expansion of its retail distribution of its domestic-use saltshakers with a new placement in Loblaws, one of Canada's largest supermarket retailers.

The new distribution is for both the 2oz and 6oz saltshakers which are expected to be available in stores by October 2024. United Natural Foods will be the distribution partner to support the Loblaws placement.

MicroSalt is also pleased to announce it has retained LeBeau Excel sales and marketing brokerage, a leading food broker in the Canadian natural and organic industry, to support and expand sales within the Canadian market.

Rick Guiney, CEO of MicroSalt, said:

"We are extremely excited about the placement of MicroSalt® shakers in Loblaws. Loblaws is one of the largest supermarket chains in Canada and a prominent fixture in the Canadian food landscape. Additionally, we are enthusiastic to partner with LeBeau Excel to expand our business, across all customer channels in Canada."

About Loblaws

Loblaws is well known for its innovative private label products such as No Name® and President's Choice®, which offer high-quality goods at competitive prices. Loblaws operates over 2,400 stores across Canada, many of which are run by independent owners, providing a full range of shopping experiences, from discount outlets like No Frills® to more upscale options like Loblaws CityMarket. In addition to groceries, Loblaw also owns Shoppers Drug Mart, offering pharmaceuticals and health services, further cementing its position as a significant retailer in Canada. For further information about Loblaws, see https://www.loblaws.ca/.

About MicroSalt®

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers and is a potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium.

Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK.

Microsalt's all natural, low-sodium solution is well positioned to take advantage of the fast-growing market for

Ignore Wally. Wait for Microsalt/Guident to be bought out at many multiples of current valuations then pay the dividend Imho

No correction needed we are drilling exploration wells again. Which is the right thing to do but this isn't DH strategy as much as he will try to spin otherwise. He has failed and isn't good for Pantheon IMHO

Baxi

As a very long term holder of Pantheon Resources I have the complete opposite view.

DH has been shoe horned in to Pantheon and quite frankly has completely failed in his strategy. Where is the reserve back lending promised in March then June. He has played out a hypothetical theory in public and delivered a share price back down at 17p with a binary drill before us. Most of what he has said has completely been reversed in recent days.

I hope whoever put him in here is realising their huge mistake.

Pantheon doesn't look a happy ship and DH appears to be angling for a 10 year job in the US rather than explore prove up and sell asap.

As for US listing bad idea in my view very very expensive and certainly for UK shareholders to drop the UK listing would be a huge negative. I do get the feeling this is on his agenda and he will plough on regardless.

Everything he is currently trying to claim is the work of Jay Bob Justin and the team Megrez Theta West Alpum were all as a result of their work.

The one thing he was going to do was get reserve backed lending and he has 100% failed.

On bulletin boards he sung the virtues of Pantheon then came in and changed the strategy and now we are back where we first started but with a spend it like Beckham attitude and doesn't look a team player.

My vote is Hobbs Out

AIMHO

GLA

Risk reward is very attractive down here. The drop to 17p is all around raise of money it shouldn't be down here.

David Hobbs has to take massive responsibility for this imho.

Take advantage gifts like this don't come around too often Magrez is one he'll of a well imho.

Your talking out of your Clenchedcheeks imho

Sea just seems the only thing you miss spell?

I think everyone has heard a million times your not happy its not adding anything. TEK is valued at a fraction of assets value like many UK companies especially AIM companies mainly due to UK funds and Pension funds choosing to not invest in the UK and in particular AIM. Nothing any CEO can do about that build the assets and value will come through. We are sat with several outstanding assets and playing these through to the end game is where the big money is. You can sit and moan as much as you like but it wont change anything or you can take advantage of the insane discount and wait for the big numbers IMHO

Sea

Its always a worry when investors can't spell the name correctly of the companies we are invested in. FWIW its Guident. You will find news today for the Company. TEK are building very significant assets news comes when it comes. All of this is supported by a huge discount to NAV imho

Agreed SpinalTap 100% bonkers.

!/2 of Microsalt market cap for anyone to justify this by saying Micrmay half so that supports a half valuation. FWIW it is probably more likely to double and that would support a 4 times valuation plus Guident Revive Lucyd and Belluscura.

We are potentially sat at a value where Guident is worth our current market cap.

A huge point which is being overlooked is TEK companies are effectively gaining funding external to TEK.

Very happy to keep buying at these levels we have several huge winners in our portfolio

IMHO

It does nothing because the UK marlet is investment market is weak and uk investors are littered with traders that can't add up.

Emv and Netscientific are doing a fantastic job raising sufficient capital to allow businesses to grow from acorns to large trees. They will exit some of these in due course and every one will then realise what they missed out on.

Results day tomorrow which will highlight how undervalued we are. Not expecting markets to get it as investors would sooner put money abroad in companies valued at 100's times sales because some push this as a good idea whereas investing at a third of NAV is a better investment all day long in my opinion

Excellent interview implications for many more products and industries including medical stunning imho

Something very suspicious you can sell 100,000 shares but cannot buy 500

Can't actually get a quote for 1,000 shares. Truly unbelievable imho

Amazed you can't buy 50,000 shares T2 authorities need to look in to this imho

All the underlying assets point to a massive rerate

It seems the US market has somewhat woken up to the potential of Lucyd. The stock many have written off now sits at a 2p valuation to TEK up circa 1.65p in the past week. I suspect Lucyd has an awful lot further to run.

Of course TEK ignores any increase similarly we continue to ignore Microsalt and Guident valuations. this was 16p not very long ago and assets are currently higher than when we were at 16p.

It is a mad old world but money will return to the small CAP AIM market this year in my view at which point TEK will be on many buy lists at much higher prices

All in my opinion

So Microsalt at £40m is taking an awful lot for granted.

Where do we see Microsalt share price on one of the Major food companies below placing volume orders.

" I am delighted that we can look ahead with the utmost confidence and in eager anticipation of further successes awaiting us".

Reading below this seems highly likely

A key focus of the business during 2023 was of our larger-volume B2B opportunities with a number of multinational FMCG companies and food manufacturers. The majority of these opportunities have now passed through the R&D phase as well as production testing and then consumer testing. In particular, the Group is now an approved supplier of Customer B and Customer C, which although separate entities, operate under the same group. Customer B launched an existing popular product now using MicroSalt in the Mexican market in the fourth quarter of 2023. In 2023, 29 mT of MicroSalt was delivered to Customer B. Customer B also provided annualised volume targets, albeit on a non-binding basis. Furthermore, the Company began negotiating a purchasing agreement and joint development agreement with Customer C which is expected to be executed in the second half of 2024.

Other selected milestones achieved during 2023 include:

• Partnership announced with Customer A for the development and execution of low-sodium solutions across the retailer's extensive line of private branded snack offerings. This will lead to placement of several of their snacks using MicroSalt® in lieu of traditional salt, beginning with 800 stores in Q4 2023 with the potential to expand across more than 7,000 store locations in the medium term;

• Agreement with supermarket chain, Giant Food of Maryland LLC, one of the most respected food retailers in the mid-Atlantic United States, to carry MicroSalt's new saltshakers across its 160 stores;

• Continued sales expansion of SaltMe! crisps and MicroSalt shakers with new placements in over 400 additional U.S. retail stores.

• Agreement with US Salt LLC for the distribution and delivery of MicroSalt's low-sodium solutions.

Very easy to get out very difficult to get back in with any volume

Yes all those doubting it are going to miss out on a massively undervalued share price. in my view